Regenerex Pharma (RGPX) Total Assets by Year
Regenerex Pharma Inc closed fiscal year 2025 with $1.3M in total assets, $5.4M in total liabilities and -$4.2M in shareholder equity. Total assets rose 64.8% from the prior fiscal year. The table below carries 15 fiscal years, from 2009 to 2025, and the quarters Regenerex Pharma Inc has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
RGPX Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-KT | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1410-K | FY1310-K | FY1210-K | FY1110-K | FY1010-K | FY0910-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.3M+64.8% | $767K+11624.7% | $7K-57.3% | $15K+46.3% | $10K-96.0% | $259K+145.4% | $106K+600.9% | $15Kn/m | -$39K | $4K-92.5% | $51K+352.3% | $11K-85.3% | $77K+1120.7% | $6K | N/A |
| Total Liabilities | $5.4M+12.2% | $4.8M+327.5% | $1.1M+12.8% | $1.0M+18.4% | $845K+14.2% | $740K+55.8% | $475K+41.4% | $336K+19.3% | $282K | $799K-54.4% | $1.8M+130.1% | $761K+282.1% | $199K+583.5% | $29K | N/A |
| Total Equity | -$4.2Mn/m | -$4.1Mn/m | -$1.1Mn/m | -$986Kn/m | -$835Kn/m | -$481Kn/m | -$370Kn/m | -$321Kn/m | -$321K | -$795Kn/m | -$1.7Mn/m | -$750Kn/m | -$122Kn/m | -$23Kn/m | -$8K |
RGPX Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q4'2510-KT | Q2'2610-Q | Q1'2610-Q | Q4'2510-KT | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $512K-33.2% | $618K-2.4% | $763K+4.7% | $1.3M+64.8% | $647K-24.1% | $633K-32.1% | $729K-29.9% | $767K+11624.7% | $852K+8482.4% | $933K+10545.4% | $1.0M+9775.6% | $7K-57.3% |
| Total Liabilities | $5.5M+14.2% | $5.3M-1.4% | $5.3M+5.3% | $5.4M+12.2% | $5.7M+20.6% | $5.4M+18.0% | $5.0M+137.5% | $4.8M+327.5% | $4.7M+335.1% | $4.6M+340.7% | $2.1M+108.3% | $1.1M+12.8% |
| Total Equity | -$5.0Mn/m | -$4.7Mn/m | -$4.5Mn/m | -$4.2Mn/m | -$5.1Mn/m | -$4.8Mn/m | -$4.3Mn/m | -$4.1Mn/m | -$3.9Mn/m | -$3.6Mn/m | -$1.1Mn/m | -$1.1Mn/m |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Regenerex Pharma Inc financials
Frequently Asked Questions
Regenerex Pharma Inc closed fiscal year 2025 with $1.3M in total assets, $5.4M in total liabilities and -$4.2M in shareholder equity.
Regenerex Pharma Inc (RGPX) total assets rose by 64.8% year over year, from $767K to $1.3M in fiscal year 2025.
Regenerex Pharma Inc (RGPX) reported $512K in total assets in Q4 2025. This represents a decrease of 33.2% from the same quarter a year earlier.
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Regenerex Pharma Inc (RGPX) reported on that line in every period on record.